Related manufacturer reference number: 2017865-2022-51070, 2017865-2022-51071.It was reported that the patient presented with bacteremia, endocarditis and vegetation during follow-up in clinic.Cultures indicated the patient had a methicillin-susceptible staphylococcus aureus (mssa) infection and antibiotics were provided.The physician explanted the system ¿ pacemaker, right atrial lead and right ventricular lead.The patient was in stable condition.
|
The device was returned due to infection.A device history record (dhr) review was performed and review of the sterilization records confirmed normal sterilization cycles for the products.All required manufacturing processes and inspection steps were confirmed to be completed per the requirements.The device met specifications prior to leaving abbott manufacturing facilities.The product was returned and visual inspection was normal.The cause of infection could not be traced to the device. a malfunction based on analysis was found as received, the device output and telemetry communication were normal.Capture test was performed on the device and it was able to capture within the product specification.Visual inspection of the header attachment area detected a bonding anomaly.The device was cut open to enable further testing and the battery was found in normal range.Hybrid circuitry was tested, and the results indicated normal current drain.A manufacturing anomaly may have occurred, which resulted in the header bonding anomaly.The device is included in the assurity and endurity pacemakers header anomaly advisory issued by abbott on 15 march 2021.
|